# South Korea Biopsy Devices Market

> South Korea Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.72%
- **2018:** $ 52.8 Million
- **2024:** $ 61.82 Million
- **2035:** $ 114 Million
- **Key Players:** Medtronic (KR), Boston Scientific (KR), Becton Dickinson (KR), Hologic (KR), Siemens Healthineers (KR), Abbott Laboratories (KR), Johnson & Johnson (KR), Cook Medical (KR)

**Report ID:** MRFR/HC/54672-HCR · **Pages:** 200 · **Author:** Satyendra Maurya · **Last Updated:** May 12, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-biopsy-devices-market-56438

---

## Market Summary

**South Korea Biopsy Devices Market Overview****:**

**As per MRFR analysis, the South Korea Biopsy Devices Market Size was estimated at 52.8 (USD Million) in 2023.****The South Korea Biopsy Devices Market Industry is expected to grow from 56.2(USD Million) in 2024 to 110.4 (USD Million) by 2035. The South Korea Biopsy Devices Market CAGR (growth rate) is expected to be around 6.33% during the forecast period (2025 - 2035).**

**Key South Korea Biopsy Devices Market Trends Highlighted**

The South Korea Biopsy Devices Market is experiencing notable changes lately due to the development of medical technologies and improved health facilities in this region. One of the factors propelling this market is the growing rate of cancer incidence in this region and increasing need for prompt diagnosis and treatment measures. There is an established South Korea healthcare system that encourages productivity through routine check-ups and also screening procedures which increases the necessity for biopsy surgeries. The government has also introduced some policies for cancer awareness and prevention which increases emphasis for these diagnostic procedures. There has been a recent shift towards the more preferable minimally invasive biopsy procedures that are associated with a faster recovery period and less patient discomfort.

The safety of procedures such as ultrasound and MRI guided biopsies is being improved with new imaging technologies that increase their precision. In addition, there is a clear movement towards automating medical processes, as seen with robotic-assisted biopsy devices. The market may also be addressed in terms of improving patient comfort along with procedural efficiency. There is an increasing need for personalized medicine which requires the development of innovative biopsy kits for faster sample collection. Moreover, healthcare providers in South Korea seeking to enhance patient outcomes have opportunities to incorporate digital health technologies into biopsies, for instance, with AI image analysis and data management.

There is significant opportunity for growth and innovation in diagnostic practices with the integration of digital health technologies to the South Korea Biopsy Devices Market as they shift toward patient-focused strategies and advanced technology.

$IMAGE1_HERe$

**South Korea Biopsy Devices Market Drivers**

Increasing Incidence of Cancer in South Korea

The rise in cancer cases in South Korea is a significant driver of the South Korea Biopsy Devices Market Industry. According to the Korean Statistical Information Service, the incidence of cancer has increased significantly, with reported cases rising from 234,000 in 2016 to approximately 278,000 in 2020. This represents an increase of around 19% over just four years, highlighting an urgent need for diagnostic tools such as biopsy devices. The National Cancer Center has continuously emphasized the importance of early detection, raising awareness about the need for advanced biopsy technologies, which directly correlates with the growth of this market.Major organizations like Samsung Medical Center and Asan Medical Center are at the forefront of implementing innovative biopsy technologies, further accelerating demand within the South Korea Biopsy Devices Market.

Technological Advancements in Biopsy Equipment

Technological advancements in biopsy devices, including the development of minimally invasive techniques and improved imaging technologies, drive growth in the South Korea Biopsy Devices Market Industry. Innovations such as robot-assisted biopsy systems and image-guided biopsy enhance accuracy and reduce patient recovery times. The Korea Health Industry Development Institute reports that the advent of automated biopsy systems, which have seen a 30% adoption rate among hospitals in urban areas, improves efficiency and effectiveness in diagnostic procedures.Furthermore, companies like Hologic and Medtronic are investing heavily in Research and Development to launch next-generation biopsy devices tailored for the South Korean healthcare system.

Growing Awareness and Screening Programs for Early Detection

Raising public awareness around the importance of early cancer detection is crucial for the growth of the South Korea Biopsy Devices Market Industry. Initiatives led by the Korean Ministry of Health and Welfare, such as periodic health check-ups and cancer screening programs, have significantly increased the number of individuals participating in cancer screening. Reports indicate that about 40% of eligible populations participated in these screening programs in 2021.This surge in routine screenings results in an increased demand for biopsy devices, as they are essential in confirming cancer diagnoses. Institutions like the Korean Society of Clinical Oncology are pivotal in promoting these screening initiatives, further bolstering market growth.

**South Korea Biopsy Devices Market Segment Insights****:**

**Biopsy Devices Market Product Type Insights**

The South Korea Biopsy Devices Market is a critical area of focus, primarily categorized into various product types that cater to different medical needs during biopsy procedures. Biopsy Guns play a pivotal role in tissue sampling, often preferred for their precision in acquiring samples, facilitating accurate diagnostics. Biopsy Guidance Systems have emerged as significant enablers, aiding clinicians by providing real-time imaging to enhance the quality of biopsies performed. Biopsy Needles are fundamental tools frequently utilized in both fine needle aspiration and core needle biopsy, showcasing their importance in minimally invasive procedures.Biopsy Forceps also contribute significantly, particularly in gastrointestinal and pulmonary examinations, allowing for effective tissue retrieval from less accessible areas. Localization Wires are essential in assisting surgeons to locate lesions prior to surgical intervention, greatly improving surgical outcomes. Additional tools categorized as others, including vacuum-assisted devices and specialized biopsy kits, supplement the market by providing diverse options tailored to various clinical settings. The South Korea Biopsy Devices Market is influenced by trends towards minimally invasive procedures, the rising prevalence of cancer, and an increasing demand for advanced diagnostic techniques, positioning this segment for notable growth opportunities.With the continuous advancements in technology and an emphasis on patient safety, the usage of these products is expected to increase, reflecting an ongoing commitment to improving healthcare outcomes in South Korea. Furthermore, government initiatives further promote the enhancement of diagnostic capabilities in the healthcare sector, contributing positively to the market landscape. Overall, the dynamics within the Product Type segment of the South Korea Biopsy Devices Market underscore the essential nature of these tools in modern medicine, catering to the needs of both healthcare professionals and patients alike.

**Biopsy Devices Market Application Insights**

The South Korea Biopsy Devices Market is categorized into various applications, playing a significant role in diagnostics and treatment. Breast biopsies are crucial as they aid in the early detection of breast cancer, which is a prevalent health issue among women in South Korea. Prostate biopsies are equally important due to the rising incidence of prostate cancer, signifying the need for effective screening and diagnosis in male populations. Liver biopsies contribute significantly to the understanding of liver diseases, while lung biopsies help in identifying lung cancers, which have become increasingly common due to rising smoking rates and air pollution.Gynecological biopsies are essential for diagnosing conditions related to women's reproductive health. Other applications include biopsies for various less common conditions, consolidating the significance of biopsy procedures in comprehensive patient care. As the demand for precise and minimally invasive diagnostic techniques continues to grow, advancements in biopsy devices are expected to enhance the efficacy and accuracy of these applications, supporting the overall health strategies in South Korea. These trends reflect a broader movement towards precision medicine and improved patient outcomes in the South Korea Biopsy Devices Market.

**Biopsy Devices Market Guidance Insights**

The Guidance segment of the South Korea Biopsy Devices Market has witnessed considerable growth owing to advancements in imaging technology and the rising prevalence of cancer. Ultrasound-Guided Biopsy is particularly significant as it offers real-time imaging, allowing for greater accuracy in targeting lesions, which enhances patient safety and comfort. Stereotactic Guided Biopsy, known for its high precision, is essential in obtaining samples from lesions that are difficult to access, making it a critical technique in breast cancer diagnosis. MRI-Guided Biopsy has also gained traction due to its ability to provide detailed images of soft tissues, which is valuable in identifying abnormalities in organs like the prostate.CT Guided Biopsy offers the advantages of speed and flexibility, making it suitable for various clinical settings, and maintains a strong presence in the market. Additionally, innovations and the emergence of alternative techniques are creating opportunities in the market. The South Korea Biopsy Devices Market shows promising potential driven by these guidance methods, addressing the growing demand for less invasive diagnostic procedures that lead to earlier disease detection and improved patient outcomes. The increasing focus on enhancing diagnostic accuracy is a major market growth driver, with healthcare providers emphasizing the adoption of these technologies for better clinical results.

**Biopsy Devices Market End User Insights**

The South Korea Biopsy Devices Market is witnessing significant traction across various End User categories, primarily driven by the increasing need for accurate diagnosis and timely disease management. Among these categories, Hospitals and Clinics represent a crucial segment due to their evolving infrastructure and advanced medical technology adoption. These facilities are often the first point of contact for patients, underscoring their importance in the initial diagnostic stages and subsequent referrals. Diagnostic and Imaging Centers play a vital role as well, as they provide specialized services to interpret biopsy results, thus facilitating better patient outcomes through enhanced detection of conditions such as cancer.Academic and Research Institutes contribute to this market by advancing biopsying techniques and developing innovative technologies, which is essential for improving the accuracy of diagnoses. Other segments encompass a broad range of facilities including laboratories and specialized clinics, and while they might hold a smaller market share relative to others, they still play an important role in providing niche services and supporting advancements in biopsy procedures. Overall, these diverse End Users collectively shape the landscape of the South Korea Biopsy Devices Market, driven by advancements in medical technology and an increasing emphasis on healthcare quality and accessibility.

**South Korea Biopsy Devices Market Key Players and Competitive Insights****:**

The South Korea Biopsy Devices Market is characterized by a dynamic and competitive landscape that reflects the country's robust healthcare sector and increasing demand for advanced diagnostic solutions. Biopsy devices play a crucial role in the early detection of diseases such as cancer, driving growth in this market segment. As healthcare providers and patients alike prioritize accurate diagnostics and minimally invasive procedures, companies are innovating and expanding their product offerings. This market has attracted both international and local players who continuously strive to enhance their technology, improve patient outcomes, and address specific regulatory requirements within South Korea. Medtronic stands as a formidable player in the South Korea Biopsy Devices Market, leveraging its global reputation for innovation and quality healthcare solutions. The company boasts a robust presence in South Korea, focusing on developing advanced biopsy technologies that align with the latest medical standards and practices. Medtronic's strengths in the region include a comprehensive range of biopsy devices that cater to various medical specialties, including oncology and gastroenterology. The company's commitment to research and development drives significant advancements in minimally invasive procedures, making it a preferred choice for many healthcare practitioners. Furthermore, Medtronic has established strong partnerships with local hospitals and clinics, enhancing its market penetration and customer loyalty in the South Korean healthcare system.Stryker is another key competitor in the South Korea Biopsy Devices Market, recognized for its innovative medical technologies and commitment to improving healthcare outcomes. The company offers a range of biopsy solutions that utilize advanced imaging techniques, ensuring precision and efficiency in diagnosis. Stryker’s market presence in South Korea is bolstered by its emphasis on quality and safety in all its product offerings. Among its key products are needle biopsy systems and other minimally invasive tools that facilitate easier access for clinical professionals. Stryker continually invests in research and development to stay ahead of market trends and maintains a strategy of strategic partnerships and acquisitions to enhance its service delivery and product lines. The company’s focus on expanding its market share in South Korea through innovative solutions and effective distribution channels reinforces its competitive position in the biopsy devices segment.

**Key Companies in the South Korea Biopsy Devices Market Include:**

Medtronic

Stryker

Abbott Laboratories

Thermo Fisher Scientific

Johnson & Johnson

Hologic

GE Healthcare

Cardinal Health

AngioDynamics

C.R. Bard

Boston Scientific

B. Braun

Siemens Healthineers

Olympus

Cook Medical

**South Korea Biopsy Devices Market Industry Developments**

_The South Korea Biopsy Devices Market has seen significant developments in recent years. In October 2023, Medtronic announced advancements in its biopsy device technology aimed at improving precision and patient outcomes. Additionally, Johnson and Johnson introduced new minimally invasive biopsy techniques that gained traction among healthcare providers. The market presently continues to expand, with a notable increase in demand for advanced diagnostic tools among South Korean hospitals, contributing to an overall market valuation growth attributed to increasing healthcare expenditures and emphasis on early detection of diseases. Furthermore, in June 2023, Abbott Laboratories bolstered its presence in the South Korean market by entering a partnership with local healthcare institutions to enhance the use of its biopsy products. There have been no significant mergers or acquisitions reported for major players like Stryker and Hologic recently. However, press releases indicated ongoing collaborations among various companies as they aim to leverage emerging technologies such as artificial intelligence in biopsy procedures. Overall, the South Korea Biopsy Devices Market is in a dynamic phase of growth due to innovation and cooperative strategies between leading healthcare corporations._

**South Korea Biopsy Devices Market Segmentation Insights**

**Biopsy Devices Market Product Type****Outlook**

**Biopsy Guns**

**Biopsy Guidance System**

**Biopsy Needles**

**Biopsy Forceps**

**Localization Wires**

**Others**

**Biopsy Devices Market Application****Outlook**

**Breast Biopsy**

**Prostate Biopsy**

**Liver Biopsy**

**Lung Biopsy**

**Gynecological Biopsy**

**Others**

**Biopsy Devices Market Guidance****Outlook**

**Ultrasound-Guided Biopsy**

**Stereotactic Guided Biopsy**

**MRI-Guided Biopsy**

**CT Guided Biopsy**

**Others**

**Biopsy Devices Market End User****Outlook**

**Hospitals & Clinics**

**Diagnostic & Imaging Centers**

**Academic & Research Institutes**

**Others**

****

## Market Drivers

### Rising Incidence of Cancer

The increasing incidence of cancer in South Korea is a critical driver for the [Biopsy Devices](https://www.marketresearchfuture.com/reports/biopsy-devices-market-2250) Market. According to recent statistics, cancer remains the leading cause of death in the country, with over 200,000 new cases reported annually. This alarming trend necessitates the use of biopsy devices for accurate diagnosis and treatment planning. As healthcare providers strive to meet the growing demand for cancer diagnostics, the market for biopsy devices is likely to expand. The South Korean government has also implemented various initiatives aimed at early cancer detection, which may further stimulate the market. Consequently, the rising cancer prevalence is expected to propel the South Korea Biopsy Devices Market, as more patients require biopsies for effective management of their conditions.

### Increase in Healthcare Expenditure

The increase in healthcare expenditure in South Korea is a substantial driver for the Biopsy Devices Market. The government has been investing heavily in healthcare infrastructure and services, with a focus on improving diagnostic capabilities. Recent reports indicate that healthcare spending is projected to rise by approximately 5% annually, which may lead to enhanced access to advanced medical technologies, including biopsy devices. This trend is likely to result in greater adoption of innovative biopsy solutions among healthcare facilities, as they seek to provide high-quality care to patients. As a consequence, the South Korea Biopsy Devices Market is expected to flourish, supported by increased funding and resources dedicated to improving diagnostic accuracy and patient outcomes.

### Growing Awareness of Early Diagnosis

There is a growing awareness of the importance of early diagnosis in South Korea, which is significantly influencing the Biopsy Devices Market. Public health campaigns and educational initiatives are emphasizing the need for regular screenings and timely interventions, particularly for cancer. This heightened awareness is likely to lead to an increase in the number of patients seeking biopsies as part of their diagnostic process. Healthcare providers are responding to this trend by investing in advanced biopsy technologies to meet the rising demand. Consequently, the South Korea Biopsy Devices Market is expected to benefit from this shift towards proactive healthcare, as more individuals prioritize early detection and treatment of diseases.

### Regulatory Support for Medical Innovations

Regulatory support plays a pivotal role in shaping the South Korea Biopsy Devices Market. The government has established a favorable regulatory framework that encourages innovation and expedites the approval process for new medical devices. This supportive environment is likely to attract investments from both domestic and international companies, fostering competition and driving technological advancements. Moreover, the Ministry of Food and Drug Safety (MFDS) has been actively promoting initiatives to streamline the approval process for innovative biopsy devices, which may enhance market growth. As a result, the South Korea Biopsy Devices Market is poised for expansion, with an increasing number of innovative products entering the market, thereby improving patient care and outcomes.

### Technological Advancements in Biopsy Devices

The South Korea Biopsy Devices Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as automated biopsy systems and image-guided biopsy techniques are enhancing the precision and efficiency of procedures. For instance, the integration of artificial intelligence in imaging systems is likely to improve diagnostic accuracy, thereby increasing the demand for advanced biopsy devices. Furthermore, the introduction of minimally invasive techniques is expected to reduce patient recovery time, which may lead to higher adoption rates among healthcare providers. As a result, the market is projected to grow significantly, with estimates suggesting a compound annual growth rate (CAGR) of around 8% over the next five years. This trend indicates a robust future for the South Korea Biopsy Devices Market, driven by continuous innovation and improved patient outcomes.

## Future Outlook

The South Korea Biopsy Devices Market is projected to grow at a 5.72% CAGR from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising healthcare expenditure.

**New opportunities:**

- Development of AI-integrated biopsy systems for enhanced diagnostic accuracy. Expansion of minimally invasive biopsy techniques in outpatient settings. Partnerships with telemedicine platforms for remote biopsy consultations.

By 2035, the market is expected to be robust, driven by innovation and strategic partnerships.

## Segment Insights

### By Application: Cancer Diagnosis (Largest) vs. Infectious Disease Diagnosis (Fastest-Growing)

In the South Korea Biopsy Devices Market, the Application segment showcases a diverse array of hitherto established medical needs, with Cancer Diagnosis holding the largest share. This segment is underpinned by a significant emphasis on early detection and personalized treatment approaches, making it crucial for both patients and healthcare providers. Infectious Disease Diagnosis, while smaller in comparison, is rapidly gaining traction, driven by increasing awareness and advancements in diagnostic methodologies. The growth trends within this segment are notable, particularly with the rising incidence of cancers and infectious diseases in South Korea. Key drivers include technological advancements in biopsy techniques and an increase in government initiatives to enhance healthcare infrastructure. As a result, the landscape is evolving, with both segments poised for increased adoption as healthcare systems continue to innovate and expand services to meet patient needs.

Cancer Diagnosis (Dominant) vs. Infectious Disease Diagnosis (Emerging)

Cancer Diagnosis remains the dominant force in the South Korea Biopsy Devices Market, characterized by its established protocols and wide utilization in oncology practices. This segment is supported by an extensive range of advanced biopsy techniques that facilitate accurate and timely diagnosis, critical for effective patient management. On the other hand, Infectious Disease Diagnosis is an emerging segment that is rapidly evolving due to the growing burden of infectious diseases and the introduction of more precise and rapid diagnostic tools. This segment is gaining attention for its potential to enhance patient outcomes, especially in acute care settings. With an increased focus on [infection control](https://www.marketresearchfuture.com/reports/infection-control-market-5901) and diagnosis, both segments are positioned to complement each other and enhance overall healthcare delivery.

### By Device Type: Needle Biopsy Devices (Largest) vs. Surgical Biopsy Devices (Fastest-Growing)

In the South Korea Biopsy Devices Market, [Needle Biopsy](https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830) Devices account for the largest share, reaffirming their crucial role in diagnostic procedures. Surgical Biopsy Devices, while trailing in market share, are noted for their innovative approaches that are capturing increasing interest among healthcare professionals. This segment's distribution illustrates the established dominance of needle biopsies and the growing acceptance of surgical alternatives in various clinical settings.

Needle Biopsy Devices (Dominant) vs. Surgical Biopsy Devices (Emerging)

Needle Biopsy Devices have emerged as the dominant player in the South Korean market owing to their effectiveness and ability to yield high-quality tissue samples for pathological examination. These devices are preferred for their minimally invasive nature, resulting in quicker recovery times for patients. Conversely, Surgical Biopsy Devices are emerging rapidly in this landscape, propelled by advancements in surgical techniques and technologies. Their appeal lies in their capability to collect larger biopsies, which offers enhanced diagnostic accuracy. As practitioners seek to provide comprehensive care, the need for reliable surgical biopsy options is forecasted to accelerate their market adoption.

### By End User: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

In the South Korea Biopsy Devices Market, hospitals command a significant share, driven by their extensive infrastructure and resources for various biopsies. Their comprehensive healthcare services cater to a large population, making them a primary end user of biopsy devices. Conversely, diagnostic laboratories are rapidly gaining ground, positioning themselves as the fastest-growing segment. They provide specialized diagnostic services and are increasingly being integrated into outpatient care, enhancing their market presence. Growth trends in this segment are being propelled by advancements in biopsy technologies, which have enabled quicker and more accurate diagnoses. The rise in cancer awareness, coupled with governmental support and investments in healthcare infrastructure, are contributing factors. Additionally, the shift towards minimally invasive procedures in hospitals and a growing emphasis on early detection in diagnostic laboratories are expected to further drive growth in this sector.

Hospitals (Dominant) vs. Research Institutions (Emerging)

Hospitals typically lead the South Korea Biopsy Devices Market due to their extensive services, ranging from outpatient care to advanced surgical procedures. They possess large and state-of-the-art facilities that are well-equipped for conducting various biopsy types, which serves a large patient demographic. In contrast, research institutions represent an emerging segment in this market. These entities focus on developing innovative biopsy methods and enhancing existing technologies, thereby contributing to the overall growth of the market. Although smaller in market share compared to hospitals, research institutions often collaborate with hospitals for clinical trials and advancements in biopsy practices, which positions them strategically for future growth.

### By Technology: Ultrasound-Guided Biopsy (Largest) vs. CT-Guided Biopsy (Fastest-Growing)

In the South Korea Biopsy Devices Market, the distribution of market share among various technologies reveals that Ultrasound-Guided Biopsy holds a significant lead as the largest segment. Its widespread adoption is largely due to its ability to provide real-time imaging, resulting in higher accuracy and patient safety during biopsy procedures. Following closely, CT-Guided Biopsy showcases a growing presence, with its use becoming increasingly prevalent in scenarios where deeper lesions need to be targeted. The presence of such advantages drives steady growth across both segments. The growth trends indicate a favorable trajectory for both Ultrasound-Guided and CT-Guided Biopsies in South Korea. Factors contributing to the expansion of the Ultrasound segment include technological advancements that enhance imaging capabilities and improve procedural efficiency. Meanwhile, the rapid growth of CT-Guided Biopsy can be attributed to its role in [cancer diagnostics](https://www.marketresearchfuture.com/reports/cancer-diagnostics-market-1962), with healthcare providers increasingly recognizing its importance in accurate tumor localization and patient outcomes. The ongoing demand for minimally invasive procedures is likely to continue driving the development and adoption of both technologies in the coming years.

Technology: Ultrasound-Guided Biopsy (Dominant) vs. CT-Guided Biopsy (Emerging)

In the South Korea Biopsy Devices Market, Ultrasound-Guided Biopsy is characterized by its established position as the dominant imaging technique for guiding biopsies. It utilizes real-time visualization to enhance precision, reduce complications, and expedite recovery times, making it a preferred choice among healthcare professionals. The effectiveness of this method, combined with increasing investments in ultrasound technology, positions it favorably within the market. On the other hand, CT-Guided Biopsy is emerging rapidly due to its efficacy in targeting challenging lesions that are not easily accessible through other methods. Its rising adoption highlights a shift towards more advanced imaging solutions within oncology, as practitioners strive for optimal diagnostic accuracy. As such, while Ultrasound-Guided Biopsy remains dominant, CT-Guided Biopsy is carving out a significant niche, indicating a shift towards diversified technological options in the biopsy landscape.

## Competitive Benchmarking

The South Korea Biopsy Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for minimally invasive procedures. Key players such as Medtronic (KR), Boston Scientific (KR), and Hologic (KR) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (KR) focuses on innovation through the development of advanced imaging technologies, while Boston Scientific (KR) emphasizes strategic partnerships to expand its product offerings. Hologic (KR), on the other hand, is concentrating on regional expansion to tap into the growing healthcare infrastructure in South Korea. Collectively, these strategies contribute to a competitive environment that is increasingly shaped by technological innovation and collaborative efforts.
In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which appears to be a prevalent trend in the market. The competitive structure of the South Korea Biopsy Devices Market is moderately fragmented, with several key players exerting influence. This fragmentation allows for a diverse range of products and services, fostering competition that drives innovation and enhances patient care.
In January 2026, Medtronic (KR) announced the launch of a new biopsy device that integrates AI technology to improve diagnostic accuracy. This strategic move is significant as it positions Medtronic (KR) as a leader in the integration of AI within biopsy procedures, potentially enhancing patient outcomes and streamlining workflows for healthcare providers. The introduction of such advanced technology may also set a new standard in the market, compelling competitors to innovate further.
In December 2025, Boston Scientific (KR) entered into a partnership with a local healthcare provider to enhance its distribution network in South Korea. This collaboration is likely to strengthen Boston Scientific's (KR) market position by improving access to its biopsy devices, thereby increasing its market share. Such strategic alliances are crucial in navigating the complexities of the South Korean healthcare landscape, where localized knowledge and relationships can significantly impact success.
In November 2025, Hologic (KR) expanded its product line by acquiring a smaller biotech firm specializing in novel biopsy techniques. This acquisition is indicative of Hologic's (KR) commitment to innovation and its strategy to diversify its offerings. By integrating new technologies and expertise, Hologic (KR) aims to enhance its competitive edge and respond to the evolving needs of the market.
As of February 2026, current competitive trends in the South Korea Biopsy Devices Market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, allowing companies to leverage shared resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage.

## Recent News & Developments

_The South Korea Biopsy Devices Market has seen significant developments in recent years. In October 2023, Medtronic announced advancements in its biopsy device technology aimed at improving precision and patient outcomes. Additionally, Johnson and Johnson introduced new minimally invasive biopsy techniques that gained traction among healthcare providers. The market presently continues to expand, with a notable increase in demand for advanced diagnostic tools among South Korean hospitals, contributing to an overall market valuation growth attributed to increasing healthcare expenditures and emphasis on early detection of diseases. Furthermore, in June 2023, Abbott Laboratories bolstered its presence in the South Korean market by entering a partnership with local healthcare institutions to enhance the use of its biopsy products. There have been no significant mergers or acquisitions reported for major players like Stryker and Hologic recently. However, press releases indicated ongoing collaborations among various companies as they aim to leverage emerging technologies such as artificial intelligence in biopsy procedures. Overall, the South Korea Biopsy Devices Market is in a dynamic phase of growth due to innovation and cooperative strategies between leading healthcare corporations._

## Report Scope

Report Scope:

| Report Attribute/Metric Source: | Details |
| --- | --- |
| MARKET SIZE 2018 | 52.8(USD Million) |
| MARKET SIZE 2024 | 56.2(USD Million) |
| MARKET SIZE 2035 | 110.4(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.33% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Medtronic, Stryker, Abbott Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Hologic, GE Healthcare, Cardinal Health, AngioDynamics, C.R. Bard, Boston Scientific, B. Braun, Siemens Healthineers, Olympus, Cook Medical |
| SEGMENTS COVERED | Product Type, Application, Guidance, End User |
| KEY MARKET OPPORTUNITIES | Growing demand for minimally invasive procedures, Increasing prevalence of cancer cases, Advancements in imaging technologies, Rising healthcare expenditure, Expansion of diagnostics and research facilities |
| KEY MARKET DYNAMICS | Rising cancer incidence, Technological advancements, Increasing aging population, Growing healthcare expenditure, Enhanced diagnostic accuracy |
| COUNTRIES COVERED | South Korea |

## Frequently Asked Questions

**Q: What is the current valuation of the South Korea Biopsy Devices Market?**
A: As of 2024, the market valuation was 61.82 USD Million.

**Q: What is the projected market size for the South Korea Biopsy Devices Market by 2035?**
A: The market is projected to reach 114.0 USD Million by 2035.

**Q: What is the expected CAGR for the South Korea Biopsy Devices Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 5.72%.

**Q: Which application segment holds the highest market value in the South Korea Biopsy Devices Market?**
A: The Cancer Diagnosis segment had a market value of 45.0 USD Million in 2024.

**Q: What are the key device types in the South Korea Biopsy Devices Market?**
A: Key device types include Needle Biopsy Devices, Surgical Biopsy Devices, Vacuum-Assisted Biopsy Devices, and Fine Needle Aspiration Biopsy Devices.

**Q: Which end user segment is projected to have the highest growth in the South Korea Biopsy Devices Market?**
A: Hospitals, with a market value of 45.0 USD Million in 2024, are likely to see significant growth.

**Q: What technology segment is expected to drive innovation in the South Korea Biopsy Devices Market?**
A: Ultrasound-Guided Biopsy technology, valued at 38.0 USD Million in 2024, appears to be a key driver of innovation.

**Q: Who are the leading players in the South Korea Biopsy Devices Market?**
A: Key players include Medtronic, Boston Scientific, Becton Dickinson, Hologic, Siemens Healthineers, Abbott Laboratories, Johnson & Johnson, and Cook Medical.

**Q: What was the market value for Vacuum-Assisted Biopsy Devices in 2024?**
A: The market value for Vacuum-Assisted Biopsy Devices was 36.0 USD Million in 2024.

**Q: How does the market for Infectious Disease Diagnosis compare to other segments?**
A: The Infectious Disease Diagnosis segment had a market value of 25.0 USD Million in 2024, indicating a robust position relative to other segments.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-biopsy-devices-market-56438*